cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vanda Pharmaceuticals Inc
7 own
15 watching
Current Price
$7.65
$-0.18
(-2.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
432.9M
52-Week High
52-Week High
14.15
52-Week Low
52-Week Low
6.73
Average Volume
Average Volume
0.59M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
29.8155
iconMarket Capitalization432.9M
icon52-Week High14.15
icon52-Week Low6.73
iconAverage Volume0.59M
iconDividend Yield--
iconP/E Ratio29.8155
What does the Vanda Pharmaceuticals Inc do?
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. The company's marketed products include HETLIOZ (tasimelteon), a product for the treatment of non-24-hour sleep-wake disorder; and Fanapt (iloperidone), a product for the treatment of schizophrenia. Its clinical development products include Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis; Trichostatin A, a small molecule histone deacetylase inhibitor, which is in development for the treatment of hematologic malignancies; and AQW051, a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. The company markets its products in the United States, Canada, Europe Union, Israel, and Mexico. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Read More
How much money does Vanda Pharmaceuticals Inc make?
News & Events about Vanda Pharmaceuticals Inc.
PR Newswire
29days ago
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference PR Newswire WASHINGTON, Jan. 6, 2023 WASHINGTON, Jan. 6, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq...
PR Newswire
2 months ago
Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study of VQW-765 in the Treatment of Acute Performance Anxiety Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study of VQW-765 in the Treatment of Acute Performance Anxiety PR Newswire WASHINGTON, Dec. 2, 2022 WASHINGTON...
PR Newswire
2 months ago
Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences PR Newswire WASHINGTON, Nov. 8, 2022 WASHINGTON, Nov. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA...
PR Newswire
3 months ago
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera PR Newswire WASHINGTON, Oct. 21, 2022 WASHINGTON...
Ticker Report
3 months ago
Equities researchers at StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA Get Rating) in a research report issued on Wednesday. The firm set a buy rating on the biopharmaceutical companys stock. Vanda Pharmaceuticals Stock Performance Shares ...
Frequently Asked Questions
Frequently Asked Questions
What is Vanda Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Vanda Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Vanda Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Vanda Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vanda Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Vanda Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Vanda Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vanda Pharmaceuticals Inc?
plus_minus_icon
What percentage is Vanda Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vanda Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.65
$-0.18
(-2.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00